Cellebrite DI (CLBT) EBT (2020 - 2026)

Cellebrite DI has reported EBT for 7 years, with the latest figure at $11.2 million in Q2 2026.

• On a quarterly basis, EBT fell 46.19% year-over-year to $11.2 million in Q2 2026; TTM through Jun 2026 was $75.4 million, a 152.16% increase from a year earlier, with the FY2025 full-year figure at $90.7 million, up 132.86% from the prior year.
• EBT was $11.2 million for Q2 2026 at Cellebrite DI, down from $13.6 million in the prior quarter.
• The five-year high for EBT was $54.5 million in Q1 2022, with the low at -$204.5 million in Q3 2024.
• Average EBT over 5 years is -$6.4 million, with a median of $12.4 million recorded in 2026.
• The sharpest annual moves came in 2022 and 2024: EBT surged 1141.26% in 2022, then plunged 3086.38% in 2024.
• Over 5 years, EBT stood at $9.1 million in 2022, then sank by 235.63% to -$12.3 million in 2023, then jumped by 261.17% to $19.9 million in 2024, then jumped by 32.03% to $26.3 million in 2025, then sank by 57.42% to $11.2 million in 2026.
• The last three EBT figures came in at $11.2 million (Q2 2026), $13.6 million (Q1 2026), and $26.3 million (Q4 2025), per Business Quant data.